ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings Inc (0SZI)

0,00
0,00
(0,00%)
Geschlossen 28 Juni 5:30PM

Corbus Pharmaceuticals Holdings Inc (0SZI) Aktie

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
-
( - )
Gebot
0,00
Fragen
0,00
Volumen
3.844
0,00 Tagesbereich 0,00
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
Handelsende
0,00
Handelsbeginn
-
Letzte Trade
117
@
8.52
(O)
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 430.335
Ausgegebene Aktien
18.527.795
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-1,46
Gewinn pro Aktie (EPS)
-5,66
Erlöse (LTM)
-
Nettogewinn (LTM)
-84,53M

Über Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin ... Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts. Mehr anzeigen

Sektor
-
Branche
-
Hauptsitz
Norwood, United States
Gegründet
2026
Corbus Pharmaceuticals Holdings Inc is listed in the sector of the Londoner Börse with ticker 0SZI. The last closing price for Corbus Pharmaceuticals was US$0,00. Over the last year, Corbus Pharmaceuticals shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Corbus Pharmaceuticals currently has 18.527.795 shares in issue. Corbus Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.46.

0SZI Neueste Nachrichten

Keine Nachrichten vorhanden.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DE
40000000DE
120000000DE
260000000DE
520000000DE
1560000000DE
2600000000DE

0SZI - Frequently Asked Questions (FAQ)

What is the current Corbus Pharmaceuticals Holdings Inc share price?
The current share price of Corbus Pharmaceuticals Holdings Inc is US$ 0,00
How many Corbus Pharmaceuticals Holdings Inc shares are in issue?
Corbus Pharmaceuticals Holdings Inc has 18.527.795 shares in issue
What is the 1 year trading range for Corbus Pharmaceuticals Holdings Inc share price?
Corbus Pharmaceuticals Holdings Inc has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the PE ratio of Corbus Pharmaceuticals Holdings Inc?
The price to earnings ratio of Corbus Pharmaceuticals Holdings Inc is -1,46
What is the registered address of Corbus Pharmaceuticals Holdings Inc?
The registered address for Corbus Pharmaceuticals Holdings Inc is 500 River Ridge Drive, Norwood, Massachusetts, 02062
What is the Corbus Pharmaceuticals Holdings Inc website address?
The website address for Corbus Pharmaceuticals Holdings Inc is www.corbuspharma.com

0SZI Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen